PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CMRX vs. JEPQ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between CMRX and JEPQ is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

CMRX vs. JEPQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Chimerix, Inc. (CMRX) and JPMorgan Nasdaq Equity Premium Income ETF (JEPQ). The values are adjusted to include any dividend payments, if applicable.

0.00%100.00%200.00%300.00%400.00%SeptemberOctoberNovemberDecember2025February
416.95%
15.27%
CMRX
JEPQ

Key characteristics

Sharpe Ratio

CMRX:

1.54

JEPQ:

1.79

Sortino Ratio

CMRX:

7.57

JEPQ:

2.37

Omega Ratio

CMRX:

1.90

JEPQ:

1.35

Calmar Ratio

CMRX:

3.54

JEPQ:

2.20

Martin Ratio

CMRX:

14.85

JEPQ:

9.30

Ulcer Index

CMRX:

23.53%

JEPQ:

2.54%

Daily Std Dev

CMRX:

226.73%

JEPQ:

13.17%

Max Drawdown

CMRX:

-98.66%

JEPQ:

-16.82%

Current Drawdown

CMRX:

-91.00%

JEPQ:

-0.19%

Returns By Period

In the year-to-date period, CMRX achieves a 48.56% return, which is significantly higher than JEPQ's 4.40% return.


CMRX

YTD

48.56%

1M

34.64%

6M

417.00%

1Y

334.45%

5Y*

24.56%

10Y*

-19.15%

JEPQ

YTD

4.40%

1M

2.26%

6M

15.27%

1Y

24.58%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CMRX vs. JEPQ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CMRX
The Risk-Adjusted Performance Rank of CMRX is 9595
Overall Rank
The Sharpe Ratio Rank of CMRX is 8888
Sharpe Ratio Rank
The Sortino Ratio Rank of CMRX is 9999
Sortino Ratio Rank
The Omega Ratio Rank of CMRX is 9898
Omega Ratio Rank
The Calmar Ratio Rank of CMRX is 9696
Calmar Ratio Rank
The Martin Ratio Rank of CMRX is 9595
Martin Ratio Rank

JEPQ
The Risk-Adjusted Performance Rank of JEPQ is 7373
Overall Rank
The Sharpe Ratio Rank of JEPQ is 7474
Sharpe Ratio Rank
The Sortino Ratio Rank of JEPQ is 7070
Sortino Ratio Rank
The Omega Ratio Rank of JEPQ is 7878
Omega Ratio Rank
The Calmar Ratio Rank of JEPQ is 6868
Calmar Ratio Rank
The Martin Ratio Rank of JEPQ is 7373
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CMRX vs. JEPQ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Chimerix, Inc. (CMRX) and JPMorgan Nasdaq Equity Premium Income ETF (JEPQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CMRX, currently valued at 1.54, compared to the broader market-2.000.002.001.541.79
The chart of Sortino ratio for CMRX, currently valued at 7.57, compared to the broader market-4.00-2.000.002.004.006.007.572.37
The chart of Omega ratio for CMRX, currently valued at 1.90, compared to the broader market0.501.001.502.001.901.35
The chart of Calmar ratio for CMRX, currently valued at 4.15, compared to the broader market0.002.004.006.004.152.20
The chart of Martin ratio for CMRX, currently valued at 14.85, compared to the broader market-10.000.0010.0020.0030.0014.859.30
CMRX
JEPQ

The current CMRX Sharpe Ratio is 1.54, which is comparable to the JEPQ Sharpe Ratio of 1.79. The chart below compares the historical Sharpe Ratios of CMRX and JEPQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00SeptemberOctoberNovemberDecember2025February
1.54
1.79
CMRX
JEPQ

Dividends

CMRX vs. JEPQ - Dividend Comparison

CMRX has not paid dividends to shareholders, while JEPQ's dividend yield for the trailing twelve months is around 9.51%.


TTM202420232022
CMRX
Chimerix, Inc.
0.00%0.00%0.00%0.00%
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
9.51%9.66%10.02%9.44%

Drawdowns

CMRX vs. JEPQ - Drawdown Comparison

The maximum CMRX drawdown since its inception was -98.66%, which is greater than JEPQ's maximum drawdown of -16.82%. Use the drawdown chart below to compare losses from any high point for CMRX and JEPQ. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February0
-0.19%
CMRX
JEPQ

Volatility

CMRX vs. JEPQ - Volatility Comparison

Chimerix, Inc. (CMRX) has a higher volatility of 16.34% compared to JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) at 3.33%. This indicates that CMRX's price experiences larger fluctuations and is considered to be riskier than JEPQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%120.00%SeptemberOctoberNovemberDecember2025February
16.34%
3.33%
CMRX
JEPQ
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab